George Yu
Keine laufenden Positionen mehr
Profil
George Yu is the founder of Medisun Precision Medicine Ltd.
founded in 2012, where he held the titles of President, Chief Executive Officer, CFO & Director from 2014 to 2017.
He was also the President, Chief Executive Officer, CFO & Director of Logiq, Inc. in 2012 and the Chief Financial Officer & Director of SinoBiomed, Inc. from 2010 to 2011.
Dr. Yu holds a doctorate from Eberhard Karls Universität Tübingen and an MBA from Columbia Business School.
Ehemalige bekannte Positionen von George Yu
| Unternehmen | Position | Ende |
|---|---|---|
| MEDISUN PRECISION MEDICINE LTD. | Vorstandsvorsitzender | 19.01.2017 |
SinoBiomed, Inc.
 SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products. | Präsident | 16.06.2011 |
| LOGIQ, INC. | Präsident | 20.12.2012 |
Ausbildung von George Yu
| Eberhard Karls Universität Tübingen | Doctorate Degree |
| Columbia Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LOGIQ, INC. | Technology Services |
| Private Unternehmen | 2 |
|---|---|
Medisun Precision Medicine Ltd.
 Medisun Precision Medicine Ltd. BiotechnologyHealth Technology Medisun Precision Medicine Ltd. is a biotechnology company, which focuses on developing novel neurological therapies to be directly delivered into specific regions of the brain. It portfolio includes ACX-31 program to deliver two chemotherapy drugs, temozolomide in combination with BCNU, locally to brain tumor sites. The company was founded on August 29, 2012 and is headquartered in Majuro, Marshall Islands. | Health Technology |
SinoBiomed, Inc.
SinoBiomed, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activities are researching, developing, testing and evaluating proposed new pharmaceutical products. Other activity includes developing cosmetic products. | Health Technology |
